Global Emergency Hemostatic Agent Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Emergency Hemostatic Agent Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Emergency Hemostatic Agent by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Emergency Hemostatic Agent by Country/Region, 2017, 2022 & 2028

2.2 Emergency Hemostatic Agent Segment by Type

2.2.1 Gelation Sponge

2.2.2 Oxidized Regenerated Cellulose Based Hemostats

2.2.3 Others

2.3 Emergency Hemostatic Agent Sales by Type

2.3.1 Global Emergency Hemostatic Agent Sales Market Share by Type (2017-2022)

2.3.2 Global Emergency Hemostatic Agent Revenue and Market Share by Type (2017-2022)

2.3.3 Global Emergency Hemostatic Agent Sale Price by Type (2017-2022)

2.4 Emergency Hemostatic Agent Segment by Application

2.4.1 Hospitals

2.4.2 Surgical Centers

2.4.3 Clnics

2.4.4 Others

2.5 Emergency Hemostatic Agent Sales by Application

2.5.1 Global Emergency Hemostatic Agent Sale Market Share by Application (2017-2022)

2.5.2 Global Emergency Hemostatic Agent Revenue and Market Share by Application (2017-2022)

2.5.3 Global Emergency Hemostatic Agent Sale Price by Application (2017-2022)

3 Global Emergency Hemostatic Agent by Company

3.1 Global Emergency Hemostatic Agent Breakdown Data by Company

3.1.1 Global Emergency Hemostatic Agent Annual Sales by Company (2020-2022)

3.1.2 Global Emergency Hemostatic Agent Sales Market Share by Company (2020-2022)

3.2 Global Emergency Hemostatic Agent Annual Revenue by Company (2020-2022)

3.2.1 Global Emergency Hemostatic Agent Revenue by Company (2020-2022)

3.2.2 Global Emergency Hemostatic Agent Revenue Market Share by Company (2020-2022)

3.3 Global Emergency Hemostatic Agent Sale Price by Company

3.4 Key Manufacturers Emergency Hemostatic Agent Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Emergency Hemostatic Agent Product Location Distribution

3.4.2 Players Emergency Hemostatic Agent Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Emergency Hemostatic Agent by Geographic Region

4.1 World Historic Emergency Hemostatic Agent Market Size by Geographic Region (2017-2022)

4.1.1 Global Emergency Hemostatic Agent Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Emergency Hemostatic Agent Annual Revenue by Geographic Region

4.2 World Historic Emergency Hemostatic Agent Market Size by Country/Region (2017-2022)

4.2.1 Global Emergency Hemostatic Agent Annual Sales by Country/Region (2017-2022)

4.2.2 Global Emergency Hemostatic Agent Annual Revenue by Country/Region

4.3 Americas Emergency Hemostatic Agent Sales Growth

4.4 APAC Emergency Hemostatic Agent Sales Growth

4.5 Europe Emergency Hemostatic Agent Sales Growth

4.6 Middle East & Africa Emergency Hemostatic Agent Sales Growth

5 Americas

5.1 Americas Emergency Hemostatic Agent Sales by Country

5.1.1 Americas Emergency Hemostatic Agent Sales by Country (2017-2022)

5.1.2 Americas Emergency Hemostatic Agent Revenue by Country (2017-2022)

5.2 Americas Emergency Hemostatic Agent Sales by Type

5.3 Americas Emergency Hemostatic Agent Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Emergency Hemostatic Agent Sales by Region

6.1.1 APAC Emergency Hemostatic Agent Sales by Region (2017-2022)

6.1.2 APAC Emergency Hemostatic Agent Revenue by Region (2017-2022)

6.2 APAC Emergency Hemostatic Agent Sales by Type

6.3 APAC Emergency Hemostatic Agent Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Emergency Hemostatic Agent by Country

7.1.1 Europe Emergency Hemostatic Agent Sales by Country (2017-2022)

7.1.2 Europe Emergency Hemostatic Agent Revenue by Country (2017-2022)

7.2 Europe Emergency Hemostatic Agent Sales by Type

7.3 Europe Emergency Hemostatic Agent Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Emergency Hemostatic Agent by Country

8.1.1 Middle East & Africa Emergency Hemostatic Agent Sales by Country (2017-2022)

8.1.2 Middle East & Africa Emergency Hemostatic Agent Revenue by Country (2017-2022)

8.2 Middle East & Africa Emergency Hemostatic Agent Sales by Type

8.3 Middle East & Africa Emergency Hemostatic Agent Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Emergency Hemostatic Agent

10.3 Manufacturing Process Analysis of Emergency Hemostatic Agent

10.4 Industry Chain Structure of Emergency Hemostatic Agent

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Emergency Hemostatic Agent Distributors

11.3 Emergency Hemostatic Agent Customer

12 World Forecast Review for Emergency Hemostatic Agent by Geographic Region

12.1 Global Emergency Hemostatic Agent Market Size Forecast by Region

12.1.1 Global Emergency Hemostatic Agent Forecast by Region (2023-2028)

12.1.2 Global Emergency Hemostatic Agent Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Emergency Hemostatic Agent Forecast by Type

12.7 Global Emergency Hemostatic Agent Forecast by Application

13 Key Players Analysis

13.1 Ethicon

13.1.1 Ethicon Company Information

13.1.2 Ethicon Emergency Hemostatic Agent Product Offered

13.1.3 Ethicon Emergency Hemostatic Agent Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Ethicon Main Business Overview

13.1.5 Ethicon Latest Developments

13.2 Pfizer

13.2.1 Pfizer Company Information

13.2.2 Pfizer Emergency Hemostatic Agent Product Offered

13.2.3 Pfizer Emergency Hemostatic Agent Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Pfizer Main Business Overview

13.2.5 Pfizer Latest Developments

13.3 Baxter International

13.3.1 Baxter International Company Information

13.3.2 Baxter International Emergency Hemostatic Agent Product Offered

13.3.3 Baxter International Emergency Hemostatic Agent Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Baxter International Main Business Overview

13.3.5 Baxter International Latest Developments

13.4 C. R. Bard

13.4.1 C. R. Bard Company Information

13.4.2 C. R. Bard Emergency Hemostatic Agent Product Offered

13.4.3 C. R. Bard Emergency Hemostatic Agent Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 C. R. Bard Main Business Overview

13.4.5 C. R. Bard Latest Developments

13.5 The Medicines Company

13.5.1 The Medicines Company Company Information

13.5.2 The Medicines Company Emergency Hemostatic Agent Product Offered

13.5.3 The Medicines Company Emergency Hemostatic Agent Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 The Medicines Company Main Business Overview

13.5.5 The Medicines Company Latest Developments

13.6 Anika Therapeutics

13.6.1 Anika Therapeutics Company Information

13.6.2 Anika Therapeutics Emergency Hemostatic Agent Product Offered

13.6.3 Anika Therapeutics Emergency Hemostatic Agent Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Anika Therapeutics Main Business Overview

13.6.5 Anika Therapeutics Latest Developments

13.7 Advanced Medical Solutions

13.7.1 Advanced Medical Solutions Company Information

13.7.2 Advanced Medical Solutions Emergency Hemostatic Agent Product Offered

13.7.3 Advanced Medical Solutions Emergency Hemostatic Agent Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Advanced Medical Solutions Main Business Overview

13.7.5 Advanced Medical Solutions Latest Developments

13.8 Integra LifeSciences

13.8.1 Integra LifeSciences Company Information

13.8.2 Integra LifeSciences Emergency Hemostatic Agent Product Offered

13.8.3 Integra LifeSciences Emergency Hemostatic Agent Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Integra LifeSciences Main Business Overview

13.8.5 Integra LifeSciences Latest Developments

13.9 B Braun Melsungen

13.9.1 B Braun Melsungen Company Information

13.9.2 B Braun Melsungen Emergency Hemostatic Agent Product Offered

13.9.3 B Braun Melsungen Emergency Hemostatic Agent Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 B Braun Melsungen Main Business Overview

13.9.5 B Braun Melsungen Latest Developments

13.10 Gelita Medical

13.10.1 Gelita Medical Company Information

13.10.2 Gelita Medical Emergency Hemostatic Agent Product Offered

13.10.3 Gelita Medical Emergency Hemostatic Agent Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Gelita Medical Main Business Overview

13.10.5 Gelita Medical Latest Developments

13.11 Equimedical

13.11.1 Equimedical Company Information

13.11.2 Equimedical Emergency Hemostatic Agent Product Offered

13.11.3 Equimedical Emergency Hemostatic Agent Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Equimedical Main Business Overview

13.11.5 Equimedical Latest Developments

13.12 Vascular Solutions

13.12.1 Vascular Solutions Company Information

13.12.2 Vascular Solutions Emergency Hemostatic Agent Product Offered

13.12.3 Vascular Solutions Emergency Hemostatic Agent Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Vascular Solutions Main Business Overview

13.12.5 Vascular Solutions Latest Developments

13.13 Marine Polymer Technologies

13.13.1 Marine Polymer Technologies Company Information

13.13.2 Marine Polymer Technologies Emergency Hemostatic Agent Product Offered

13.13.3 Marine Polymer Technologies Emergency Hemostatic Agent Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Marine Polymer Technologies Main Business Overview

13.13.5 Marine Polymer Technologies Latest Developments

13.14 Z-Medica

13.14.1 Z-Medica Company Information

13.14.2 Z-Medica Emergency Hemostatic Agent Product Offered

13.14.3 Z-Medica Emergency Hemostatic Agent Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Z-Medica Main Business Overview

13.14.5 Z-Medica Latest Developments

13.15 CryoLife

13.15.1 CryoLife Company Information

13.15.2 CryoLife Emergency Hemostatic Agent Product Offered

13.15.3 CryoLife Emergency Hemostatic Agent Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 CryoLife Main Business Overview

13.15.5 CryoLife Latest Developments

13.16 BioCer Entwicklungs

13.16.1 BioCer Entwicklungs Company Information

13.16.2 BioCer Entwicklungs Emergency Hemostatic Agent Product Offered

13.16.3 BioCer Entwicklungs Emergency Hemostatic Agent Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 BioCer Entwicklungs Main Business Overview

13.16.5 BioCer Entwicklungs Latest Developments

13.17 Biom’Up SAS

13.17.1 Biom’Up SAS Company Information

13.17.2 Biom’Up SAS Emergency Hemostatic Agent Product Offered

13.17.3 Biom’Up SAS Emergency Hemostatic Agent Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Biom’Up SAS Main Business Overview

13.17.5 Biom’Up SAS Latest Developments

14 Research Findings and Conclusion

Table 1. Emergency Hemostatic Agent Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Emergency Hemostatic Agent Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Gelation Sponge

Table 4. Major Players of Oxidized Regenerated Cellulose Based Hemostats

Table 5. Major Players of Others

Table 6. Global Emergency Hemostatic Agent Sales by Type (2017-2022) & (K Units)

Table 7. Global Emergency Hemostatic Agent Sales Market Share by Type (2017-2022)

Table 8. Global Emergency Hemostatic Agent Revenue by Type (2017-2022) & ($ million)

Table 9. Global Emergency Hemostatic Agent Revenue Market Share by Type (2017-2022)

Table 10. Global Emergency Hemostatic Agent Sale Price by Type (2017-2022) & (US$/Unit)

Table 11. Global Emergency Hemostatic Agent Sales by Application (2017-2022) & (K Units)

Table 12. Global Emergency Hemostatic Agent Sales Market Share by Application (2017-2022)

Table 13. Global Emergency Hemostatic Agent Revenue by Application (2017-2022)

Table 14. Global Emergency Hemostatic Agent Revenue Market Share by Application (2017-2022)

Table 15. Global Emergency Hemostatic Agent Sale Price by Application (2017-2022) & (US$/Unit)

Table 16. Global Emergency Hemostatic Agent Sales by Company (2020-2022) & (K Units)

Table 17. Global Emergency Hemostatic Agent Sales Market Share by Company (2020-2022)

Table 18. Global Emergency Hemostatic Agent Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Emergency Hemostatic Agent Revenue Market Share by Company (2020-2022)

Table 20. Global Emergency Hemostatic Agent Sale Price by Company (2020-2022) & (US$/Unit)

Table 21. Key Manufacturers Emergency Hemostatic Agent Producing Area Distribution and Sales Area

Table 22. Players Emergency Hemostatic Agent Products Offered

Table 23. Emergency Hemostatic Agent Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Emergency Hemostatic Agent Sales by Geographic Region (2017-2022) & (K Units)

Table 27. Global Emergency Hemostatic Agent Sales Market Share Geographic Region (2017-2022)

Table 28. Global Emergency Hemostatic Agent Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Emergency Hemostatic Agent Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Emergency Hemostatic Agent Sales by Country/Region (2017-2022) & (K Units)

Table 31. Global Emergency Hemostatic Agent Sales Market Share by Country/Region (2017-2022)

Table 32. Global Emergency Hemostatic Agent Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Emergency Hemostatic Agent Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Emergency Hemostatic Agent Sales by Country (2017-2022) & (K Units)

Table 35. Americas Emergency Hemostatic Agent Sales Market Share by Country (2017-2022)

Table 36. Americas Emergency Hemostatic Agent Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Emergency Hemostatic Agent Revenue Market Share by Country (2017-2022)

Table 38. Americas Emergency Hemostatic Agent Sales by Type (2017-2022) & (K Units)

Table 39. Americas Emergency Hemostatic Agent Sales Market Share by Type (2017-2022)

Table 40. Americas Emergency Hemostatic Agent Sales by Application (2017-2022) & (K Units)

Table 41. Americas Emergency Hemostatic Agent Sales Market Share by Application (2017-2022)

Table 42. APAC Emergency Hemostatic Agent Sales by Region (2017-2022) & (K Units)

Table 43. APAC Emergency Hemostatic Agent Sales Market Share by Region (2017-2022)

Table 44. APAC Emergency Hemostatic Agent Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Emergency Hemostatic Agent Revenue Market Share by Region (2017-2022)

Table 46. APAC Emergency Hemostatic Agent Sales by Type (2017-2022) & (K Units)

Table 47. APAC Emergency Hemostatic Agent Sales Market Share by Type (2017-2022)

Table 48. APAC Emergency Hemostatic Agent Sales by Application (2017-2022) & (K Units)

Table 49. APAC Emergency Hemostatic Agent Sales Market Share by Application (2017-2022)

Table 50. Europe Emergency Hemostatic Agent Sales by Country (2017-2022) & (K Units)

Table 51. Europe Emergency Hemostatic Agent Sales Market Share by Country (2017-2022)

Table 52. Europe Emergency Hemostatic Agent Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Emergency Hemostatic Agent Revenue Market Share by Country (2017-2022)

Table 54. Europe Emergency Hemostatic Agent Sales by Type (2017-2022) & (K Units)

Table 55. Europe Emergency Hemostatic Agent Sales Market Share by Type (2017-2022)

Table 56. Europe Emergency Hemostatic Agent Sales by Application (2017-2022) & (K Units)

Table 57. Europe Emergency Hemostatic Agent Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Emergency Hemostatic Agent Sales by Country (2017-2022) & (K Units)

Table 59. Middle East & Africa Emergency Hemostatic Agent Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Emergency Hemostatic Agent Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Emergency Hemostatic Agent Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Emergency Hemostatic Agent Sales by Type (2017-2022) & (K Units)

Table 63. Middle East & Africa Emergency Hemostatic Agent Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Emergency Hemostatic Agent Sales by Application (2017-2022) & (K Units)

Table 65. Middle East & Africa Emergency Hemostatic Agent Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Emergency Hemostatic Agent

Table 67. Key Market Challenges & Risks of Emergency Hemostatic Agent

Table 68. Key Industry Trends of Emergency Hemostatic Agent

Table 69. Emergency Hemostatic Agent Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Emergency Hemostatic Agent Distributors List

Table 72. Emergency Hemostatic Agent Customer List

Table 73. Global Emergency Hemostatic Agent Sales Forecast by Region (2023-2028) & (K Units)

Table 74. Global Emergency Hemostatic Agent Sales Market Forecast by Region

Table 75. Global Emergency Hemostatic Agent Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Emergency Hemostatic Agent Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Emergency Hemostatic Agent Sales Forecast by Country (2023-2028) & (K Units)

Table 78. Americas Emergency Hemostatic Agent Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Emergency Hemostatic Agent Sales Forecast by Region (2023-2028) & (K Units)

Table 80. APAC Emergency Hemostatic Agent Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Emergency Hemostatic Agent Sales Forecast by Country (2023-2028) & (K Units)

Table 82. Europe Emergency Hemostatic Agent Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Emergency Hemostatic Agent Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Middle East & Africa Emergency Hemostatic Agent Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Emergency Hemostatic Agent Sales Forecast by Type (2023-2028) & (K Units)

Table 86. Global Emergency Hemostatic Agent Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Emergency Hemostatic Agent Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Emergency Hemostatic Agent Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Emergency Hemostatic Agent Sales Forecast by Application (2023-2028) & (K Units)

Table 90. Global Emergency Hemostatic Agent Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Emergency Hemostatic Agent Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Emergency Hemostatic Agent Revenue Market Share Forecast by Application (2023-2028)

Table 93. Ethicon Basic Information, Emergency Hemostatic Agent Manufacturing Base, Sales Area and Its Competitors

Table 94. Ethicon Emergency Hemostatic Agent Product Offered

Table 95. Ethicon Emergency Hemostatic Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 96. Ethicon Main Business

Table 97. Ethicon Latest Developments

Table 98. Pfizer Basic Information, Emergency Hemostatic Agent Manufacturing Base, Sales Area and Its Competitors

Table 99. Pfizer Emergency Hemostatic Agent Product Offered

Table 100. Pfizer Emergency Hemostatic Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 101. Pfizer Main Business

Table 102. Pfizer Latest Developments

Table 103. Baxter International Basic Information, Emergency Hemostatic Agent Manufacturing Base, Sales Area and Its Competitors

Table 104. Baxter International Emergency Hemostatic Agent Product Offered

Table 105. Baxter International Emergency Hemostatic Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 106. Baxter International Main Business

Table 107. Baxter International Latest Developments

Table 108. C. R. Bard Basic Information, Emergency Hemostatic Agent Manufacturing Base, Sales Area and Its Competitors

Table 109. C. R. Bard Emergency Hemostatic Agent Product Offered

Table 110. C. R. Bard Emergency Hemostatic Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 111. C. R. Bard Main Business

Table 112. C. R. Bard Latest Developments

Table 113. The Medicines Company Basic Information, Emergency Hemostatic Agent Manufacturing Base, Sales Area and Its Competitors

Table 114. The Medicines Company Emergency Hemostatic Agent Product Offered

Table 115. The Medicines Company Emergency Hemostatic Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 116. The Medicines Company Main Business

Table 117. The Medicines Company Latest Developments

Table 118. Anika Therapeutics Basic Information, Emergency Hemostatic Agent Manufacturing Base, Sales Area and Its Competitors

Table 119. Anika Therapeutics Emergency Hemostatic Agent Product Offered

Table 120. Anika Therapeutics Emergency Hemostatic Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 121. Anika Therapeutics Main Business

Table 122. Anika Therapeutics Latest Developments

Table 123. Advanced Medical Solutions Basic Information, Emergency Hemostatic Agent Manufacturing Base, Sales Area and Its Competitors

Table 124. Advanced Medical Solutions Emergency Hemostatic Agent Product Offered

Table 125. Advanced Medical Solutions Emergency Hemostatic Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 126. Advanced Medical Solutions Main Business

Table 127. Advanced Medical Solutions Latest Developments

Table 128. Integra LifeSciences Basic Information, Emergency Hemostatic Agent Manufacturing Base, Sales Area and Its Competitors

Table 129. Integra LifeSciences Emergency Hemostatic Agent Product Offered

Table 130. Integra LifeSciences Emergency Hemostatic Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 131. Integra LifeSciences Main Business

Table 132. Integra LifeSciences Latest Developments

Table 133. B Braun Melsungen Basic Information, Emergency Hemostatic Agent Manufacturing Base, Sales Area and Its Competitors

Table 134. B Braun Melsungen Emergency Hemostatic Agent Product Offered

Table 135. B Braun Melsungen Emergency Hemostatic Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 136. B Braun Melsungen Main Business

Table 137. B Braun Melsungen Latest Developments

Table 138. Gelita Medical Basic Information, Emergency Hemostatic Agent Manufacturing Base, Sales Area and Its Competitors

Table 139. Gelita Medical Emergency Hemostatic Agent Product Offered

Table 140. Gelita Medical Emergency Hemostatic Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 141. Gelita Medical Main Business

Table 142. Gelita Medical Latest Developments

Table 143. Equimedical Basic Information, Emergency Hemostatic Agent Manufacturing Base, Sales Area and Its Competitors

Table 144. Equimedical Emergency Hemostatic Agent Product Offered

Table 145. Equimedical Emergency Hemostatic Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 146. Equimedical Main Business

Table 147. Equimedical Latest Developments

Table 148. Vascular Solutions Basic Information, Emergency Hemostatic Agent Manufacturing Base, Sales Area and Its Competitors

Table 149. Vascular Solutions Emergency Hemostatic Agent Product Offered

Table 150. Vascular Solutions Emergency Hemostatic Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 151. Vascular Solutions Main Business

Table 152. Vascular Solutions Latest Developments

Table 153. Marine Polymer Technologies Basic Information, Emergency Hemostatic Agent Manufacturing Base, Sales Area and Its Competitors

Table 154. Marine Polymer Technologies Emergency Hemostatic Agent Product Offered

Table 155. Marine Polymer Technologies Emergency Hemostatic Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 156. Marine Polymer Technologies Main Business

Table 157. Marine Polymer Technologies Latest Developments

Table 158. Z-Medica Basic Information, Emergency Hemostatic Agent Manufacturing Base, Sales Area and Its Competitors

Table 159. Z-Medica Emergency Hemostatic Agent Product Offered

Table 160. Z-Medica Emergency Hemostatic Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 161. Z-Medica Main Business

Table 162. Z-Medica Latest Developments

Table 163. CryoLife Basic Information, Emergency Hemostatic Agent Manufacturing Base, Sales Area and Its Competitors

Table 164. CryoLife Emergency Hemostatic Agent Product Offered

Table 165. CryoLife Emergency Hemostatic Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 166. CryoLife Main Business

Table 167. CryoLife Latest Developments

Table 168. BioCer Entwicklungs Basic Information, Emergency Hemostatic Agent Manufacturing Base, Sales Area and Its Competitors

Table 169. BioCer Entwicklungs Emergency Hemostatic Agent Product Offered

Table 170. BioCer Entwicklungs Emergency Hemostatic Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 171. BioCer Entwicklungs Main Business

Table 172. BioCer Entwicklungs Latest Developments

Table 173. Biom’Up SAS Basic Information, Emergency Hemostatic Agent Manufacturing Base, Sales Area and Its Competitors

Table 174. Biom’Up SAS Emergency Hemostatic Agent Product Offered

Table 175. Biom’Up SAS Emergency Hemostatic Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 176. Biom’Up SAS Main Business

Table 177. Biom’Up SAS Latest Developments

List of Figures

Figure 1. Picture of Emergency Hemostatic Agent

Figure 2. Emergency Hemostatic Agent Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Emergency Hemostatic Agent Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Emergency Hemostatic Agent Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Emergency Hemostatic Agent Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Gelation Sponge

Figure 10. Product Picture of Oxidized Regenerated Cellulose Based Hemostats

Figure 11. Product Picture of Others

Figure 12. Global Emergency Hemostatic Agent Sales Market Share by Type in 2021

Figure 13. Global Emergency Hemostatic Agent Revenue Market Share by Type (2017-2022)

Figure 14. Emergency Hemostatic Agent Consumed in Hospitals

Figure 15. Global Emergency Hemostatic Agent Market: Hospitals (2017-2022) & (K Units)

Figure 16. Emergency Hemostatic Agent Consumed in Surgical Centers

Figure 17. Global Emergency Hemostatic Agent Market: Surgical Centers (2017-2022) & (K Units)

Figure 18. Emergency Hemostatic Agent Consumed in Clnics

Figure 19. Global Emergency Hemostatic Agent Market: Clnics (2017-2022) & (K Units)

Figure 20. Emergency Hemostatic Agent Consumed in Others

Figure 21. Global Emergency Hemostatic Agent Market: Others (2017-2022) & (K Units)

Figure 22. Global Emergency Hemostatic Agent Sales Market Share by Application (2017-2022)

Figure 23. Global Emergency Hemostatic Agent Revenue Market Share by Application in 2021

Figure 24. Emergency Hemostatic Agent Revenue Market by Company in 2021 ($ Million)

Figure 25. Global Emergency Hemostatic Agent Revenue Market Share by Company in 2021

Figure 26. Global Emergency Hemostatic Agent Sales Market Share by Geographic Region (2017-2022)

Figure 27. Global Emergency Hemostatic Agent Revenue Market Share by Geographic Region in 2021

Figure 28. Global Emergency Hemostatic Agent Sales Market Share by Region (2017-2022)

Figure 29. Global Emergency Hemostatic Agent Revenue Market Share by Country/Region in 2021

Figure 30. Americas Emergency Hemostatic Agent Sales 2017-2022 (K Units)

Figure 31. Americas Emergency Hemostatic Agent Revenue 2017-2022 ($ Millions)

Figure 32. APAC Emergency Hemostatic Agent Sales 2017-2022 (K Units)

Figure 33. APAC Emergency Hemostatic Agent Revenue 2017-2022 ($ Millions)

Figure 34. Europe Emergency Hemostatic Agent Sales 2017-2022 (K Units)

Figure 35. Europe Emergency Hemostatic Agent Revenue 2017-2022 ($ Millions)

Figure 36. Middle East & Africa Emergency Hemostatic Agent Sales 2017-2022 (K Units)

Figure 37. Middle East & Africa Emergency Hemostatic Agent Revenue 2017-2022 ($ Millions)

Figure 38. Americas Emergency Hemostatic Agent Sales Market Share by Country in 2021

Figure 39. Americas Emergency Hemostatic Agent Revenue Market Share by Country in 2021

Figure 40. United States Emergency Hemostatic Agent Revenue Growth 2017-2022 ($ Millions)

Figure 41. Canada Emergency Hemostatic Agent Revenue Growth 2017-2022 ($ Millions)

Figure 42. Mexico Emergency Hemostatic Agent Revenue Growth 2017-2022 ($ Millions)

Figure 43. Brazil Emergency Hemostatic Agent Revenue Growth 2017-2022 ($ Millions)

Figure 44. APAC Emergency Hemostatic Agent Sales Market Share by Region in 2021

Figure 45. APAC Emergency Hemostatic Agent Revenue Market Share by Regions in 2021

Figure 46. China Emergency Hemostatic Agent Revenue Growth 2017-2022 ($ Millions)

Figure 47. Japan Emergency Hemostatic Agent Revenue Growth 2017-2022 ($ Millions)

Figure 48. South Korea Emergency Hemostatic Agent Revenue Growth 2017-2022 ($ Millions)

Figure 49. Southeast Asia Emergency Hemostatic Agent Revenue Growth 2017-2022 ($ Millions)

Figure 50. India Emergency Hemostatic Agent Revenue Growth 2017-2022 ($ Millions)

Figure 51. Australia Emergency Hemostatic Agent Revenue Growth 2017-2022 ($ Millions)

Figure 52. Europe Emergency Hemostatic Agent Sales Market Share by Country in 2021

Figure 53. Europe Emergency Hemostatic Agent Revenue Market Share by Country in 2021

Figure 54. Germany Emergency Hemostatic Agent Revenue Growth 2017-2022 ($ Millions)

Figure 55. France Emergency Hemostatic Agent Revenue Growth 2017-2022 ($ Millions)

Figure 56. UK Emergency Hemostatic Agent Revenue Growth 2017-2022 ($ Millions)

Figure 57. Italy Emergency Hemostatic Agent Revenue Growth 2017-2022 ($ Millions)

Figure 58. Russia Emergency Hemostatic Agent Revenue Growth 2017-2022 ($ Millions)

Figure 59. Middle East & Africa Emergency Hemostatic Agent Sales Market Share by Country in 2021

Figure 60. Middle East & Africa Emergency Hemostatic Agent Revenue Market Share by Country in 2021

Figure 61. Egypt Emergency Hemostatic Agent Revenue Growth 2017-2022 ($ Millions)

Figure 62. South Africa Emergency Hemostatic Agent Revenue Growth 2017-2022 ($ Millions)

Figure 63. Israel Emergency Hemostatic Agent Revenue Growth 2017-2022 ($ Millions)

Figure 64. Turkey Emergency Hemostatic Agent Revenue Growth 2017-2022 ($ Millions)

Figure 65. GCC Country Emergency Hemostatic Agent Revenue Growth 2017-2022 ($ Millions)

Figure 66. Manufacturing Cost Structure Analysis of Emergency Hemostatic Agent in 2021

Figure 67. Manufacturing Process Analysis of Emergency Hemostatic Agent

Figure 68. Industry Chain Structure of Emergency Hemostatic Agent

Figure 69. Channels of Distribution

Figure 70. Distributors Profiles